GHTRX Mutual Fund

GHTRX Mutual Fund

NAV$19.43
Do a full portfolio x-ray with GHTRX
Just $25 once·$69/mo·Download sample
Get mine for $25

Fund Essentials - as of Mar 31, 2026

Net Assets
$729M
Expense Ratio
0.89%
Dividend Yield (Current)
1.94%
Holdings
282
Inception Date
Apr 30, 2018
Fund Family
Goldman Sachs Asset Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.35%
1 Year+30.47%
3 Year+20.52%
5 Year+11.79%
10 Year+10.59%

Asset Allocation

Stocks: 100.03%
Do a full portfolio x-ray with GHTRX
$25 once. No subscription. Download sample.
Get mine for $25

Top Holdings

View All →
TickerNameWeight
AZN:LNAstraZeneca PLC2.34%
NOVN:SMNovartis Ag – Class N2.28%
ASML:ASASML HOLDING NV2.17%
NESN:SMNestlã S.A., Registered Shares1.82%
ABBN:SMAbb Ltd1.47%
Top 10 Concentration: 16.37%Report Date: Mar 31, 2026
Download all 282 holdings for GHTRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.94%
Frequency
Annually
Latest Distribution
$0.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

GHTRX Mutual Fund Overview

GHTRX Mutual Fund (Goldman Sachs International Tax-Managed Equity Fund Class R6) is managed by Goldman Sachs Asset Management with $729.3M in net assets. GHTRX expense ratio is 0.89%, holding 282 positions across sectors including Financials, Materials, Industrials. Inception date: 2018-04-30.

GHTRX performance shows a YTD return of 13.35%. The 1-year return is 30.47% and the 5-year return is 11.79%. GHTRX dividend yield stands at 1.94%, paid annually.

GHTRX top holdings include AstraZeneca PLC (2.3%), Novartis Ag – Class N (2.3%), ASML HOLDING NV (2.2%), Nestlã S.A., Registered Shares (1.8%), Abb Ltd (1.5%). Go to all GHTRX holdings, GHTRX sectors, or GHTRX dividends.

GHTRX can be compared against other funds. Use GHTRX overlap to find shared positions, or GHTRX vs another fund for a side-by-side view. GHTRX alternatives are available via the screener, along with tax-loss harvesting opportunities.